Talaris Therapeutics Inc (TALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TALS | CNTX | AVTX | ||
| Company | Talaris Therapeutics Inc | Context Therapeutics Inc | Avalo Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.80 | 1.5300 | 10.69 | ||
| High | 27.95 | 1.5849 | 10.88 | ||
| Low | 26.90 | 1.3201 | 9.60 | ||
| Last | 27.20 | 1.5000 | 9.65 | ||
| Change | -0.20 | -0.1300 | -1.25 | ||
| % Change | -0.73% | -7.98% | -11.47% | ||
| Volume | 30,520 | 578,500 | 88,400 | ||
| 20-Day Average Volume | 179,555 | 196,225 | 69,100 | ||
| Previous Close | 27.40 | 1.6300 | 10.90 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.76 | 2.0230 | 12.79 | ||
| 20-Day Raw Stochastic | 31.67% | 16.66% | 0.78% | ||
| 20-Day Relative Strength | 46.92% | 31.76% | 39.52% | ||
| Weighted Alpha | +66.50 | +20.71 | -76.95 | ||
| Today's Opinion | Hold | 40% Sell | 8% Sell | ||
| Previous Opinion | 8% Buy | 40% Sell | 32% Buy | ||
| Last Month's Opinion | 48% Buy | 64% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.74% since 10/12/23 | -21.05% since 11/14/24 | -28.41% since 11/14/24 | ||
| Low | 2.60 on 10/18/23 | 1.3201 on 11/21/24 | 9.60 on 11/21/24 | ||
| High | 3.13 on 10/16/23 | 1.8900 on 11/15/24 | 13.50 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -6.85% since 09/19/23 | -27.18% since 10/21/24 | -16.01% since 10/21/24 | ||
| Low | 2.53 on 10/10/23 | 1.3201 on 11/21/24 | 9.60 on 11/21/24 | ||
| High | 3.13 on 10/16/23 | 2.5899 on 10/23/24 | 16.00 on 10/28/24 | ||
| 3-Month | |||||
| %Chg | -9.63% since 07/19/23 | -40.24% since 08/21/24 | +11.56% since 08/21/24 | ||
| Low | 2.53 on 10/10/23 | 1.3201 on 11/21/24 | 6.84 on 08/30/24 | ||
| High | 3.13 on 10/16/23 | 2.6200 on 08/27/24 | 16.00 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | +23.64% since 04/19/23 | -26.11% since 05/21/24 | -11.63% since 05/21/24 | ||
| Low | 2.15 on 04/20/23 | 1.3201 on 11/21/24 | 6.84 on 08/30/24 | ||
| High | 3.29 on 07/10/23 | 2.7500 on 08/14/24 | 16.00 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 116,318 | 122,247 | 113,295 | ||
| Shares Outstanding, K | 42,764 | 74,998 | 10,394 | ||
| Annual Sales | 0 | 0 | 1,920,000 | ||
| Annual Net Income | -73,890,000 | -23,960,000 | -31,540,000 | ||
| Last Quarter Sales | 0 | 0 | 250,000 | ||
| Last Quarter Net Income | -14,740,000 | -17,460,000 | 23,040,000 | ||
| 60-Month Beta | 2.18 | 2.25 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 08/14/23 | -0.22 on 11/06/24 | -2.83 on 11/07/24 | ||
| Latest Earnings Date | 11/09/23 | 11/14/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||